NCT07537491

Brief Summary

Perioperative complications following surgery for colorectal cancer (CRC) represent a major cause of postoperative morbidity and mortality. Existing risk stratification tools lack the precision to capture the complex biological and morphological factors that determine individual patient vulnerability. Artificial intelligence (AI)-based analysis of medical imaging data offers a promising approach to improve preoperative risk prediction. The KIA-Korekt study investigates whether perioperative complications in CRC patients can be predicted using multimodal AI-based image analysis. Three complementary imaging modalities are integrated: digital histopathology (haematoxylin-eosin whole-slide images, H\&E-WSIs), preoperative CT and MRI radiomics, and multiplex tissue imaging (mTI) including multiplex immunohistochemistry (mIHC) and imaging mass cytometry (IMC). The study includes a retrospective cohort of approximately 750 CRC patients treated between 2011 and 2021, and a prospective validation cohort of approximately 210 patients recruited from 2026 to 2028. Deep learning and radiomic feature extraction pipelines are applied to all modalities individually and in multimodal combination. Predicted outcomes include anastomotic leakage, wound infection, sepsis, ICU admission, and in-hospital mortality within 30 days of surgery. The study is conducted at the University Hospital Brandenburg, Brandenburg Medical School Theodor Fontane, in collaboration with the Department of Computational Pathology, TU Dresden.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
910

participants targeted

Target at P75+ for all trials

Timeline
26mo left

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Jan 2011Jun 2028

Study Start

First participant enrolled

January 1, 2011

Completed
15.3 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

17 years

First QC Date

April 8, 2026

Last Update Submit

April 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prediction accuracy of perioperative complications

    Occurrence of postoperative complications including anastomotic leakage, sepsis, ICU admission, and in-hospital mortality. Outcomes are defined based on clinical documentation and assessed as binary variables (yes/no).

    30 days postoperative

Study Arms (2)

Group 1: Retrospective Training Cohort

Patients with colorectal cancer treated between 2011-2021 with available imaging and histopathology data.

Prospective Cohort

Patients with colorectal cancer enrolled prospectively between 2026-2028.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (≥18 years) with histologically confirmed colorectal cancer undergoing surgical treatment at a tertiary care center. The study includes both retrospectively collected patients (2011-2021) and prospectively enrolled patients (2026-2028) with available imaging and histopathological data.

You may qualify if:

  • Adult patients (≥18 years)
  • Histologically confirmed colorectal adenocarcinoma
  • Undergoing surgical resection (curative or palliative intent)
  • Availability of H\&E-stained whole-slide images (WSIs) from the primary tumour

You may not qualify if:

  • Patients not undergoing surgical treatment
  • Missing H\&E-stained tissue slides of the primary tumour
  • Histopathological material of insufficient quality for analysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Brandenburg an der Havel, Brandenburg an der Havel, Germany (Single-center)

Brandenburg an der Havel, Germany

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Univ.-Prof. Dr. med.

Study Record Dates

First Submitted

April 8, 2026

First Posted

April 17, 2026

Study Start

January 1, 2011

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Locations